Exchange Traded Concepts’s Structure Therapeutics GPCR Stock Holding History

Exchange Traded Concepts’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65M	Buy	30,773 +5,395	+21%	+$239K	0.01%	773
2026 Q1	$1.22M	Sell	25,378 -603	-2%	-$41.3K	0.01%	745
2025 Q4	$1.81M	Sell	25,981 -32,241	-55%	-$1.32M	0.01%	615
2025 Q3	$1.63M	Sell	58,222 -3,510	-6%	-$69.9K	0.01%	621
2025 Q2	$1.28M	Buy	61,732 +22,809	+59%	+$502K	0.02%	593
2025 Q1	$674K	Sell	38,923 -1,512	-4%	-$37K	0.01%	733
2024 Q4	$1.1M	Sell	40,435 -666	-2%	-$23.6K	0.02%	527
2024 Q3	$1.8M	Buy	41,101 +27,019	+192%	+$1.04M	0.04%	357
2024 Q2	$553K	Buy	+14,082	New	+$578K	0.01%	677

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Exchange Traded Concepts's GPCR Position: Q2 2026 in Review

Exchange Traded Concepts increased its Structure Therapeutics (GPCR) stake by 21% in Q2 2026, buying an estimated $239K and bringing the position to 30,773 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #773.

Exchange Traded Concepts first reported a position in GPCR in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.81M in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Exchange Traded Concepts held 30,773 shares of Structure Therapeutics worth $1.65M as of Q2 2026.
Exchange Traded Concepts bought 5,395 Structure Therapeutics shares in Q2 2026, an estimated $239K.
Structure Therapeutics made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #773 holding.
Exchange Traded Concepts first reported a position in Structure Therapeutics in Q2 2024 and has held it in 9 quarters since.
Exchange Traded Concepts's Structure Therapeutics position peaked at $1.81M in Q4 2025.
191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.